Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

Chemistry World February 2, 2011 Andy Extance	Pfizer to close historic UK site Most of the 2400 people employed at the Pfizer site in Sandwich, UK, will be made redundant over the next 18-24 months as the US pharma giant restructures its research operations.
Chemistry World March 2011 Bea Perks	Editorial: At the forefront The news that most of Pfizer's 2400 employees at Sandwich, U.K. will be made redundant over the next two years was met with surprise, disappointment and anger.
Chemistry World August 3, 2012 Andrew Turley	Pfizer secures Sandwich buyer Pfizer has found a buyer for its R&D site in Sandwich, UK: the site -- now called Discovery Park -- has been bought by a private consortium, according to Kent County Council.
Chemistry World April 29, 2014 Phillip Broadwith	Pfizer courts AstraZeneca megamerger US-based pharma behemoth Pfizer has publically announced its intention to make a merger offer to the UK's AstraZeneca, in a deal valued at around $100 billion.
Chemistry World June 24, 2011 Andrew Turley	Pfizer to Keep 350 Jobs at Sandwich US drug giant Pfizer has said that it will keep 350 jobs at its site in Sandwich, UK.
Chemistry World January 18, 2012 Patrick Walter	Shell shutters UK R&D site The research currently carried out at the facility will be transferred to overseas sites. The announcement has fueled concerns in the UK research community that the country's opportunity to become a high-tech economy is slipping away.
Chemistry World February 2, 2012 Andrew Turley	AstraZeneca to cut 7300 more jobs UK drugmaker AstraZeneca has announced plans to cut a further 7300 jobs to make annual savings of $1.6 billion by the end of 2014, a move that will cost the company $2.1 billion in the near term.
Chemistry World September 17, 2007	Uk Pharma Shifts Manufacturing Overseas Drug firm AstraZeneca has today reiterated that it will outsource drug manufacturing.
Chemistry World May 14, 2014 Andy Extance	Pfizer presses hard for AstraZeneca deal US pharma giant Pfizer is battling a backlash of suspicion and hostility across the world over its attempts to acquire its UK-headquartered rival AstraZeneca.
Pharmaceutical Executive June 1, 2013 Julian Upton	Opening the Patent Box Are the answers to the UK pharma sector's problems to be found in the government's new "Patent Box," which introduces a lower rate of corporation tax on profits generated from UK-owned intellectual property.
Chemistry World December 8, 2015 Jennifer Newton	Pfizer to close Cambridge pain outpost Pfizer plans to shut down its Neusentis site on the outskirts of Cambridge, UK, in a move that will eliminate up to 120 jobs.
Chemistry World March 20, 2008 Richard Van Noorden	UK Drug Firms to Slash Research and Jobs The UK pharmaceutical industry is expecting to cut jobs and investment in R&D following an alarming slump in confidence in the UK market.
Chemistry World November 6, 2013 Laura Howes	Novartis to shut Horsham site Last year, the firm slammed the UK for the high cost of conducting clinical trials in the country, warning that business would leave unless more incentives were introduced to encourage firms to carry out R&D.
Pharmaceutical Executive June 1, 2013	When Gurus Get It Wrong Despite their high status, management gurus aren't always on point when it comes to pharma, writes John Ansell.
InternetNews June 3, 2010	The Long Road Back for IT Outsourcing IT outsourcing providers suffered as much or more than any other sector during heart of the economic meltdown and pundits say the recovery won't happen overnight.
Chemistry World July 9, 2008 James Mitchell Crow	Pharma goes green to cut costs The pharmaceutical industry's current drive to curb spending is helping to speed the adoption of green chemistry, say experts in the industry.
Fast Company February 1, 2008 Arianne Cohen	Scuttling Scut Work Pfizer devises a new kind of outsourcing -- just for the time-wasting parts of your job.
Chemistry World December 13, 2013 Maria Burke	UK overtakes US on research quality metric The UK has overtaken the US and now ranks first in one indicator of research quality, according to a new report commissioned by the UK's Department of Business, Innovation and Skills.
Pharmaceutical Executive December 1, 2011	UK Report: Keep Calm and Carry On ... Differently Even as the global economic roller coaster affects one of the country's dearest public institutions, the National Health Service, there is still reason for optimism in these times of austerity.
The Motley Fool July 22, 2009 Robert Steyer	Canaries in the Drug Coal Mine Contract research organizations like Pharmaceutical Product Development and ICON reflect an ailing drug industry.
Chemistry World February 2, 2007 Victoria Gill	AstraZeneca Follows Pfizer in Slashing Workforce The Anglo-Swedish pharmaceutical hopes that by streamlining its operation it can offset the growing financial threat from cheap generic copies of its best-selling blood pressure drug. Nevertheless, the company has reported unexpectedly cheerful fourth quarter profits.
Chemistry World September 10, 2015 Matthew Gunther	Research bodies urge UK government to protect science funding Nearly 200 research organizations have signed an open letter urging the UK government to protect science funding in the 2015 UK spending review.
Chemistry World May 19, 2008 Hepeng Jia	China's one stop research shop John Oyler has founded a string of startups in the US, but in 2005 he chose China as his base to launch BioDuro, a life sciences Contract Research Organisation.
The Motley Fool March 6, 2009 Brian Orelli	For Drug Companies, R&D Is Spelled C-R-O It seems likely that more and more pharma companies will try to get more bang for their bucks by spending them on research and development done outside the company, outsourcing it to clinical research organizations.
Bank Technology News December 2004 Holly Sraeel	Outsourcing Gets a Closer Look. But is It Different? The strategic value of outsourcing has always been the source of some debate in banking. The question is, "Is it different than in years past?" Good question, and the answer depends on the size of institution.
Chemistry World February 6, 2014 Patrick Walter	Clouds on the horizon for UK science The UK needs to up its game to keep up with the rest of the continent when it comes to science, Europe's research chief has said.
Chemistry World February 10, 2015 Emma Stoye	Science societies urge next UK government to invest more in research The next UK government should invest twice as much in research, according to a joint statement released by the National Academies.
Wall Street & Technology August 27, 2004 Kerry Massaro	Bringing India to You Despite the controversy over sending technology jobs to other countries, outsourcing has become a fact of life for financial institutions.
Global Services November 29, 2007	The Future of Niche IT Service Providers Going forward, large IT service providers will acquire niche service providers to gain expertise in specific verticals or horizontals.
Chemistry World September 2009	Education and wealth It seems that the UK government is interested in answering the question: what return does the UK get for the money it puts into academic research in chemistry?
Chemistry World February 14, 2007 Victoria Gill	Prescription-free Viagra From today, men in the UK will be able to buy Viagra from their pharmacist without a doctor's prescription. But the trial run of the scheme has fanned the flames of a controversy about how US drug company Pfizer markets the impotence drug.
Chemistry World November 22, 2013 Emily James	100 million for cancer research centers Cancer Research UK has invested 100 million pounds in 15 innovative research centers, acquiring high level expertise to solve the latest challenges in cancer.
Chemistry World February 2012	Navigating the stormy seas of pharma In the pharmaceutical and biotech sector, quality navigation is becoming an essential process for identifying the best route to take in order to guide business effectively in a dramatically changing environment.
CIO December 16, 2009 Stephanie Overby	DIY Outsourcing Saves Money, Adds Control Pricey IT consultants can be time savers but there are benefits -- beyond penny pinching -- to crafting your own outsourcing deal.
The Motley Fool July 27, 2011 Michael Olsen	Rising Stars Buy: Icon Icon, the fourth-largest CRO, sits among the global elite and makes for a healthy investment.
Chemistry World May 28, 2014 Phillip Broadwith	Time called on Pfizer -- AstraZeneca deal Pfizer's pursuit of a pharmaceutical megamerger has concluded with the US giant withdrawing its final offer two hours before the deadline set by the UK's takeover rules.
Chemistry World July 9, 2013 Daniel Johnson	Evotec moves business back to UK German drug discovery company Evotec will close its operations in Thane, India, and move them back to its Abingdon, UK, facility.
Global Services August 14, 2008 Phil Fersht	Dodging the Outsourcing Landmines With growing reliance on their providers to deliver, greater scrutiny by boards and their auditors, and such, driving change deep into firms, execs governing outsourcing relationships have become a lightning rod for criticism.
The Motley Fool August 27, 2011 Michael Olsen	Rising Star Buy: More Icon Icon shares might not appreciate tomorrow, and they might decline more before they go up. But here is a rare value: a secular growth story at a stellar valuation.
FAO Today Nov/Dec 2007 Bob Cecil	Deals for the Next Decade of Finance and Accounting Outsourcing Increased buyer savvy paves the way for notable shifts in deal structure.
Chemistry World November 27, 2015 Anthony King	Pfizer and Allergan agree mega-merger The deal is being positioned as Irish-based Allergan taking over Pfizer, with the merged entity resident in Ireland for tax purposes.
Chemistry World April 16, 2010 Sean Milmo	Ineos starts UK chemicals exodus Ineos's decision to relocate its headquarters to Switzerland because of corporate taxation concerns may spark an exodus of chemical and pharmaceutical companies from having their headquarters in the UK.
FAO Today Mar/Apr 2008 Lisa Ross	Department Procurement: Try Adding Procurement By outsourcing finance & accounting and procurement together, you can fan the flames of powerful synergies that will go straight to the bottom line -- while helping to improve operations.
The Motley Fool August 23, 2004 Ben McClure	Rethinking Big Pharma Risk is knocking Big Pharma stocks down. They won't be getting up anytime soon. Competition, soaring R&D costs, shifting business models, and political meddling combine to make drug stocks a riskier place to invest.
Chemistry World March 22, 2012 Andrew Turley	GSK to build 350 million factory in UK GlaxoSmithKline has announced plans to build its first new UK production plant for almost 40 years in Ulverston, Cumbria.
Chemistry World November 23, 2015 Emma Stoye	Labour would increase R&D spending to 3% of GDP The UK's shadow chancellor John McDonnell has said a Labour government would aim to raise the amount spent on R&D to 3% of GDP by 2030.
Chemistry World July 31, 2013 Andy Extance	Pfizer reshuffle hints at future split decision Pharmaceutical giant Pfizer is internally dividing its commercial operations into three business segments, which will report profits separately from 2014 onwards.
Chemistry World April 6, 2011 Andrew Turley	Pfizer sells capsule business for $2.4bn Investment firm Kohlberg Kravis Roberts has agreed to pay $2.4 billion in cash for the business, which it says has 'an excellent portfolio'.
Chemistry World July 27, 2011 Sean Milmo	UK government sets aside 1000 places for top researchers The UK chemistry sector has given a mostly cool response to a government scheme to attract top chemists, chemical engineers and other scientists from outside the EU, while tightening restrictions on immigration.
Chemistry World September 18, 2012 Laura Howes	Battery boost for electric cars The UK government, in collaboration with industry, is to create a new UK energy storage R&D center to accelerate the development of batteries for vehicles.